The field of vascular biology has suffered a tremendous loss with the passing of Dr. Stephen M. Schwartz, former Professor of Pathology at the University of Washington. He was one of the 'founding fathers' of the field and established a lasting legacy as one of the key architects of the North American Vascular Biology Organization (NAVBO). On a personal note, Steve was not only a treasured scientific colleague, but he was also a friend and mentor to me throughout my scientific career. As I grieve his loss, I have found some solace in the outpouring of messages of condolences, remembrances, profound respect and love from those who share the lasting imprint that Steve left on all of those who knew him.

I consider it a high honor to contribute to the collective memoriam for Steve. And yet, it is difficult to contemplate a more challenging task than to compose a succinct summary of Steve\'s persona and significance. As a scientist, he served as an inspiring role model as an intellectual polyglot with an insatiable curiosity and probing mind. In my encounters with Steve, he could be passionate, irreverent, erudite, iconoclastic, irascible, endearing and loyal -- sometimes in the same moment in time.

As I look back on my time as a visiting physician-scientist at the University of Washington, I\'m filled with a greater appreciation for Steve\'s burly, big-hearted mentorship and sponsorship that enhanced my career trajectory and accelerated my growth as a neophyte in the emerging field of vascular biology. I have vivid recollections of our intellectual interchanges in which his incisive, probing questions and mental parrying left me both exhausted and exhilarated. One of my enduring memories of Steve was our interchange about my lab\'s observation about apoptosis-resistance of intimal smooth muscle cells as part of their phenotype.

Conversations with Steve often carried over to the local pub or a new restaurant he\'d been eyeing. I can still see Steve holding court at a hole-in-the-wall restaurant in New Orleans, his resonant voice challenging a group of scientists he\'d invited along following scientific sessions. We debated the meaning of cell death in vascular biology, how his Sephardic Jewish heritage and my African ancestry made us distant cousins, and a range of conversation topics from Bayesian statistics to politics, race and religion. It was one of the best meals I ever had.

Steve\'s lab and mentee cohorts reflected his generous spirit and innate curiosity about the world. Long before the words "diversity and inclusion" were placed into strategic plans or accepted political correctness, Steve was welcoming bright minds of all stripes -- including women, underrepresented minorities and those of different backgrounds. As an African American physician-scientist in a field where I didn\'t see many people who looked like I did, the organic diversity I saw served as an inspiring model. Indeed, 30 years after meeting Steve and his family of mentees, his example, among others, would be at the forefront of my mind as I led the development of a "Roadmap" for diversity and inclusion at the National, Heart, Lung and Blood Institute. Our living document emphasizes an inclusive NHLBI community of continuous learners that readily embraces creativity, innovation, collaboration, and diversity of thought.

As a mentee, one of the great tributes you can express to your mentor is to become a great mentor yourself. Steve always conveyed his fond indebtedness to his mentor, Dr. Earl Benditt. At the NHLBI, Steve is considered by many program officers as one of the nation\'s most outstanding mentors with a decades-long leadership of the T32 training program in vascular biology at the University of Washington. His leadership of NAVBO extended this capacity to inspire and train the next generation.

During his 78 years, Steve achieved any scientist\'s dream: his investigations and discoveries left an indelible mark on science, and his passionate advocacy for his field left a legacy with global reach that lives on through his trainees. Indeed, our contemporary understanding of the 'intima' and atherogenesis has been shaped in part by discoveries led and inspired by Steve. Perhaps it is a bit of irony that Steve\'s life was taken by a novel coronavirus with a distinctive capacity to target the endothelium and promote vascular injury that results in the clinical sequelae of COVID-19.

Steve\'s death has engendered a very intimate and personal touch to the devastating impact of this pandemic. Our field has lost a unique life force who leaves a deep void in biomedicine and in the lives of those he mentored, but his legacy, memory, and impact endures.
